Novo Nordisk A/S vs United Microelectronics Corp — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while United Microelectronics Corp trades at $21.14 (market cap $51.00B). The key difference: Novo Nordisk A/S is far larger — about 4.3× United Microelectronics Corp's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | UMC | |
|---|---|---|
Market Cap | $220.53B | $51.00B |
Sector | Health | Technology |
52-Week High | $71.70 | $28.02 |
52-Week Low | $35.29 | $6.58 |
Enterprise Value | $239.49B | $48.57B |
Dividend Yield | 3.63% | 2.03% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →